2017
DOI: 10.1016/j.jacc.2017.03.003
|View full text |Cite|
|
Sign up to set email alerts
|

2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
86
0
10

Year Published

2017
2017
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 240 publications
(96 citation statements)
references
References 684 publications
0
86
0
10
Order By: Relevance
“…Syncope is an abrupt loss of consciousness due to transient global cerebral hypoperfusion, with a concomitant loss of postural tone and rapid, spontaneous recovery. 1 Recovery from syncope is characterized by immediate restoration of orientation and normal behavior, although the period after recovery may be accompanied by fatigue. 2 The European Society of Cardiology 2 has classifi ed syncope into 3 main categories: refl ex (neurally mediated) syncope, syncope due to orthostatic hypotension, and cardiac syncope.…”
Section: ■ Definitions Classificationsmentioning
confidence: 99%
“…Syncope is an abrupt loss of consciousness due to transient global cerebral hypoperfusion, with a concomitant loss of postural tone and rapid, spontaneous recovery. 1 Recovery from syncope is characterized by immediate restoration of orientation and normal behavior, although the period after recovery may be accompanied by fatigue. 2 The European Society of Cardiology 2 has classifi ed syncope into 3 main categories: refl ex (neurally mediated) syncope, syncope due to orthostatic hypotension, and cardiac syncope.…”
Section: ■ Definitions Classificationsmentioning
confidence: 99%
“…Studies often included a wide age range of patients despite the incidence of syncope, related ED visits, and serious outcomes increasing sharply after the age of 60. 7 Cardiac biomarkers such as troponin or BNP testing appear to be an attractive diagnostic option, however, they did not rule in or rule out cardiac syncope. Moreover, these cardiac biomarkers were likely used to diagnose cardiac syncope leading to incorporation bias.…”
Section: Caveatsmentioning
confidence: 99%
“…[13] In addition, it is used to uncover the cause of palpitations, recurrent unexplained falls, arrhythmia evaluation in obstructive sleep apnea, and for post-cardiac surgery arrhythmia evaluation. In addition, there is emerging evidence for MCT advantage in both time to initiation of drug therapy and inpatient cardiovascular patient costs.…”
Section: Contra: Paul Kligfieldmentioning
confidence: 99%
“…With an aging population, there is justifiable concern about unsustainable health care expenditures. Future research is required to determine whether a similar diagnostic yield and patient outcome could 13 be achieved with non-real time monitoring before this technology is adopted into routine care for patients at risk for arrhythmia.…”
Section: Contra: Paul Kligfieldmentioning
confidence: 99%